Filter announcements
Loading...
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specializing in manufacturing and trading medicines, including generic drugs.
Zenith Drugs Limited enhanced investor transparency by hosting a Stock Knocks session to discuss its business model, growth strategy, and industry outlook. The management emphasized plans to drive sustainable growth amid evolving market trends, aiming to strengthen stakeholder confidence. No sensitive price details were shared.
Zenith Drugs has announced a board meeting and is rapidly advancing its new Cephalosporin manufacturing facility in Indore, built to European GMP standards. The plant will produce tablets, capsules, dry powder, and injections, with commercial production slated for September 2025. This expansion enhances Zenith’s manufacturing capabilities and positions it strongly...
Zenith Drugs Limited has secured two significant tenders, strengthening its pharmaceutical sector position. The first, worth approximately ₹7.10 Cr, involves supplying cream and syrup to the Rajasthan Medical Services Corporation Limited. The second, valued at ₹94.45 Lacs, pertains to providing pharmaceutical products to government hospitals in Madhya Pradesh. These contracts...
The scheduled board meeting for Zenith Drugs Limited has been canceled due to unavoidable circumstances. This decision follows prior communications regarding its postponement. The company's strategic direction may experience some delays as a result of this cancellation, potentially affecting investor sentiment. Stakeholders should watch closely for updates on rescheduling and...
Zenith Drugs Limited has secured two significant tenders, reinforcing its role as a reliable supplier in the pharmaceutical sector. The first tender, valued at approximately Rs. 6.83 Crore, involves supplying pharmaceutical products to various government hospitals in Madhya Pradesh. This collaboration aims to enhance the healthcare infrastructure in the state,...